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Abstract
Background There remains uncertainty regarding the
relative importance of patient factors such as comorbidity
and provider factors such as hospital volume in predicting
complication rates after total hip arthroplasty (THA).
Purpose We therefore identiﬁed patient and provider
factors predicting complications after THA.
Methods We reviewed discharge data from 138,399
patients undergoing primary THA in California from 1995
to 2005. The rate of complications during the ﬁrst 90 days
postoperatively (mortality, infection, dislocation, revision,
perioperative fracture, neurologic injury, and thromboem-
bolic disease) was regressed against a variety of
independent variables, including patient factors (age, gen-
der, race/ethnicity, income, Charlson comorbidity score)
and provider variables (hospital volume, teaching status,
rural location).
Results Compared with patients treated at high-volume
hospitals (above the 20th percentile), patients treated at
low-volume hospitals (below the 60th percentile) had a
higher aggregate risk of having short-term complications
(odds ratio, 2.00). A variety of patient factors also had
associations with an increased risk of complications:
increased Charlson comorbidity score, diabetes, rheumatoid
arthritis, advanced age, male gender, and black race. His-
panic and Asian patients had lower risks of complications.
Conclusions Patient and provider characteristics affected
the risk of a short-term complication after THA. These
results may be useful for educating patients and anticipating
perioperative risks of THA in different patient populations.
Level of Evidence Level II, prognostic study. See
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
THA is effective for decreasing pain and improving the
function of patients with arthritis refractory to nonoperative
treatment with antiinﬂammatory medications, activity
modiﬁcation, and weight loss. Despite the efﬁcacy of THA,
complications can occur which result in poor functional
outcomes for a subset of patients. Given hip arthroplasty is
a common and costly procedure, documenting and
improving the quality of care and outcomes after THA
remains a priority. Identifying risk factors that predict
postoperative complications and, more speciﬁcally, being
able to predict those patients at higher risk before surgery is
an important step in searching for strategies that might
reduce short-term complication rates.
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DOI 10.1007/s11999-010-1354-0The most common major complications include mortal-
ity, infection, dislocation, revision, and pulmonary
embolism [4–6]. The rates of complication have been
reported in international registries [2, 3, 8]. In addition,
several papers have used administrative databases to evalu-
atecomplicationsinMedicarepatients,withemphasisonthe
relationshipbetweenhospitalandsurgeonvolumetoratesof
mortality and complications during the ﬁrst 90 days after
THA [4, 10]. The California Patient Discharge Database
similarly contains data on mortality and complications. The
database has the advantage of capturing complication rates
of patients in the population of a state comparable in size to
those covered in international registries. In addition, the age
range is not limited by Medicare coverage. In the absence of
a domestic joint replacement registry, the database provides
a large alternative source of information on the rates and
predictors of complication rates in a large group of patients
from the United Stated including all age groups.
Toconﬁrmreportedriskfactorsnotedintheliterature,we
therefore identiﬁed patient and provider factors predicting
complications after THA using the California database.
Patients and Methods
We obtained data for all hospitalizations in California
during the years 1995 through 2005 from California’s
Ofﬁce of Statewide Health Planning and Development
(OSHPD). The OSHPD database is compiled annually and
includes discharge abstracts from all licensed nonfederal
hospitals in California [11, 12]. Each discharge abstract
reports demographic information that includes age, gender,
insurance type, and the race or ethnicity of the patient. In
addition, International Classiﬁcation of Diseases, 9th
Revision (ICD-9) codes are entered into the record for each
patient; the number of codes entered is not prespeciﬁed and
the maximum allowed is up to 20 inpatient procedures and
24 diagnoses per hospitalization (Table 1). Hospital char-
acteristics are also reported, including the teaching status
and whether a hospital is classiﬁed as rural in location. The
OSHPD state inpatient database was initiated as a com-
ponent of the Healthcare Cost and Utilization Project
(HCUP) and is collected through mandatory reporting by
all nonfederal hospitals in the state of California. Institu-
tional Review Board approval was obtained for this study.
We identiﬁed 138,399 patients undergoing their ﬁrst
THA using the ICD-9 procedure code for primary THA
(81.51) who met inclusion and exclusion criteria. A pre-
viously published coding algorithm was modiﬁed and used
to exclude 20,291 patients with infection, pathologic frac-
ture, or undergoing revision arthroplasty [4, 10] (Appendix
1). We also excluded 3,848 patients with a non-California
zip code to decrease the probability of the patient having
prior admissions meeting exclusion criteria or experiencing
a subsequent complication treated outside of the state. The
unit of analysis was hospital discharge for each patient. All
patients had basic demographic data as mandated by the
state reporting requirements so no patients were excluded
for missing data. Baseline patient characteristics were
recorded in the database and analyzed. The mean age of the
patient sample was 66 years with 85% being white. The
population was diverse with 4% being black, 7% Hispanic,
and 2% Asian. Complicated diabetes is deﬁned as diabetes
associated with end-organ damage; uncomplicated diabetes
was noted in 8%, whereas less than 1% of patients had
complicated diabetes. A diagnosis of rheumatoid arthritis
was noted in 4% of patients (Table 1).
We selected the primary patient-based predictors: the
Charlson comorbidity index [1, 9], age, race, gender, and
income using zip code as a proxy as reported in the
OSHPD database crossreferenced to US Census data. The
Charlson comorbidity index assesses 19 comorbid condi-
tions and has been validated for use in administrative
database studies [1, 9]. This study uses the approach of
Deyo et al. that adapted the Charlson index by deﬁning the
19 comorbid conditions using ICD-9-CM coding and sub-
sequently determining if the relevant codes are included in
a patient record [1, 9]. In addition to the Charlson score,
individual comorbidities were included for separate
Table 1. Demographics of patient sample
Characteristic Description of sample
Number of patients 138,399
Mean age (standard deviation) 66 years (+/ 13 yrs.)
Gender
1) Male 1) 79,514 (57%)
2) Female 2) 58,885 (43%)
Race/Ethnicity
1) White 1) 117,107 (85%)
2) Black 2) 6,051 (4%)
3) Hispanic 3) 9,368 (7%)
4) Asian/Paciﬁc Islander 4) 3,006 (2%)
5) Other 5) 2,867 (2%)
Income\20th percentile 5,840 (4%)
Complicated diabetes 743 (\1%)
Peripheral vascular disease 2,179 (2%)
Rheumatoid arthritis 5,565 (4%)
Hospital volume
1) High 1) 27,480 (20%)
2) Intermediate 2) 56,431 (41%)
3) Low 3) 54,488 (39%)
Teaching status 18,455 (13%)
Rural location 3,128 (2%)
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123analysis consisting of diabetes, peripheral vascular disease,
and rheumatoid arthritis.
Hospitals characteristics included surgical volume of
THA, rural location, and teaching status. Teaching status
and rural location are self-reported by the participating
hospitals. Surgical volume was deﬁned as the average
number of primary THAs performed yearly during the
study period. Hospitals were classiﬁed by their annual
average volume as high-, intermediate-, or low-volume
hospitals. Hospitals were categorized as low-volume if they
were in the lowest 40th percentile by annual volume among
hospitals where THA was performed. Intermediate-volume
hospitals were deﬁned as the next 40th percentile; high-
volume hospitals were deﬁned as the highest 20th
percentile.
The outcomes analyzed as the dependent variables
were the aggregate rate of short-term complications as
well as the separately analyzed rates of individual com-
plications, including mortality or readmission for the
speciﬁc complications of infection, dislocation, revision
surgery, perioperative fracture, neurologic injury, and
thromboembolic disease at 90 days postoperatively. Pre-
viously published algorithms [4, 5] were adapted to detect
codes consistent with a complication. The coding algo-
rithms use ICD-9 nomenclature to identify patients
undergoing total hip replacement using the 81.51 proce-
dure code. Additional associated diagnoses, exclusion
criteria, and complications are deﬁned based on ICD-9
procedure and diagnoses codes judged by the authors to
be consistent with the diagnoses or complications of
interest. These algorithms were modiﬁed to correct for
coding changes made during the study period [7, 11]
(Appendix 1). Mortality was identiﬁed by the linkage of
the California State Death Statistical Master File to the
OSHPD database. This allowed us to identify hospital
deaths occurring after discharge and the time elapsed
before death in patients undergoing primary THA. The
DSMF is a database of death certiﬁcates for all individ-
uals dying in California and of those California residents
who die outside of California’s borders but within the
United States [13].
We used multiple variable logistic regression models to
determine the role of the patient and provider characteris-
tics as independent variables in predicting the occurrence
of the complications selected as dependent variables. This
method allows us to report the odds ratio for each patient
and provider independent variable adjusted for all of the
other variables included in the model. The regression
models included the patient characteristics of race/ethnic-
ity, age, gender, income, speciﬁc comorbidities, and
modiﬁed Charlson comorbidity index and the provider
characteristics of hospital volume, rural location, and
teaching status as independent variables. The strength of
association between the risk of a complication and the
patient and provider characteristics is reported as the odds
ratio in relation to a reference group adjusted for all the
other variables included in the model. P-values and 95%
conﬁdence intervals are reported with the odds ratios. All
statistical analyses were conducted using Stata/SE 8.0
(Stata Corp, College Station, TX).
Results
Overall, the 90-day complication rate after primary THA
was 3.8%. The most common complication identiﬁed was
dislocation (1.4%). The mortality rate was 0.68%. The
rates of infection, thromboembolic disease (including pul-
monary embolism and deep venous thrombosis),
neurovascular injury, perioperative fracture, and revision
surgery were each below 1% (Table 2).
Increased age was associated with a higher risk of a
short-term complication as was a higher Charlson comor-
bidity index (Table 3). One of the stronger predictors of an
increased aggregate risk of a complication within 90 days
was the presence of complicated diabetes (odds ratio [OR],
1.94; 95% conﬁdence interval [CI], 1.49–2.53; p\0.001)
as a result of increased risks of mortality and infection.
Relative to white patients, black patients had an increased
risk of complications (OR, 1.19; 95% CI, 1.05–1.35;
p = 0.007), whereas Hispanic (OR, 0.75; 95% CI, 0.67–
0.85; p\0.001) and Asian patients (OR, 0.54; 95% CI,
0.42–0.69; p\0.001) had a lower risk. Patients’ quintile
of income was not associated with the aggregate risk of a
complication. Hospital volume was the strongest predictor
of a complication with both low-volume (OR, 2.00; 95%
CI, 1.82–2.20; p\0.001) and intermediate-volume (OR,
1.33; 95% CI, 1.22–1.45; p\0.001) hospitals having an
increased OR in relation to high-volume hospitals
(Table 3). Teaching status and rural location were not
associated with increased risks for most complications
(Table 4).
Table 2. 90-day complication rates following total hip arthroplasty
Complication Rate (# of cases)
Mortality 0.68% (943)
Dislocation 1.39% (1,930)
Infection 0.70% (969)
Thromboembolic disease 0.64% (883)
Perioperative fracture 0.01% (14)
Revision surgery 0.93% (1,289)
Neurovascular Injury 0.05% (74)
Overall rate of any complication
within 90-days
3.81% (5,277)
Volume 468, Number 9, September 2010 Complication Rates After Hip Arthroplasty 2365
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Many reports from various registries and individual papers
reportriskfactors predictingcomplicationrates aftertotalhip
arthroplasty (THA). However, the ﬁndings vary and there
remains uncertainty regarding the relative importance of
patient factors such as comorbidity and provider factors such
as hospital volume in predicting complications. The Califor-
nia Ofﬁce of Statewide Health Planning and Development
(OSHPD) database provides a large alternate source of
information. To conﬁrm information in the literature, we
therefore identiﬁed patient and provider factors predicting
complications after THA using this alternate database. We
speciﬁcally report the role of a variety of patient and hospital
characteristics in predicting rates of mortality, infection,
revision,dislocation,andthromboembolicdiseaseafterTHA.
There are several limitations of studies examining
administrative databases. First, this study was performed
using a database of all patients in California over an 11-year
period; this population may be less prone to selection bias
than those studies looking at isolated Medicare populations.
However, one potential bias in this population stems from
patients having had surgery in California and sustaining a
complication elsewhere, which would go unrecorded. More
research is needed to determine if there is substantial bias in
groups moving or receiving care outside of California.
Another potential source of bias comes from relying on
administrative registries. There can be substantial discrep-
ancies between administrative data and audited and
validated clinical data [10]. Second, the use of readmission
and death records may underestimate morbidity and mor-
tality if complications are not coded properly or do not
require hospitalization. Third, the OSHPD statewide data-
base does not include information on long-term functional
outcomes.Asaresult,wecouldnotevaluatethe relationship
of the predictor variables to functional outcome. Fourth, we
were limited in our ability to identify confounding variables
suchassurgeonvolumeandtraining.Informationonsurgeon
volume was not available and could not be evaluated sepa-
rately from hospital volume. The studies by Katz et al.
suggest both surgeon volume and hospital volume are
independently associated with complication rates after THA
[4].Fifth,theCaliforniadatabase includeshospitalidentiﬁer
but not surgeon identiﬁers, so we could not identify infor-
mation on the relative importance of hospital and surgeon
volume. Despite these limitations, the California discharge
database hastheadvantageofbeingmandatedbythe stateto
include all admissions [13]. In addition, California is a large
state with a diverse population allowing for the analysis of
large numbers of patients from a variety of socioeconomic
categories. In the absence of a formal domestic registry, the
complication rates reported in this study provide an initial
Table 3. Odds ratios for a complication within 90-days according to patient and hospital characteristics
Patient or hospital characteristic Reference group 90-day overall complication risk
(Odds ratio, 95% conﬁdence interval, p-value)
Patient characteristic
Age[75 Age[65–75 1.39 (1.30–1.48, p\0.001)
Age[55–65 Age[65–75 0.89 (0.83–0.96, p = 0.005)
Age B 55 Age[65–75 0.72 (0.65–0.81, p\0.001)
Male gender Female Gender 1.10 (1.03–1.17, p = 0.02)
Black race White Race 1.19 (1.05–1.35, p = 0.007)
Hispanic ethnicity White Race 0.75 (0.67–0.85, p\0.001)
Asian race White Race 0.54 (0.42–0.69, p\0.001)
Income\80th percentile Income C 20th percentile 1.11 (0.97–1.27, p = 0.12)
Patient comorbidity
Charlson co-morbidity Continuous variable 1.21 (1.18–1.24, p\0.001)
Uncomplicated diabetes Patients without diabetes 1.31 (1.19–1.44, p\0.001)
Complicated diabetes Patients without diabetes 1.94 (1.49–2.53, p\0.001)
Peripheral vascular disease Patients without PVD 1.66 (1.30–2.11, p\0.001)
Rheumatoid disease No rheumatoid disease 1.53 (1.23–1.91, p\0.001)
Hospital characteristics
Low-volume hospitals High-volume hospitals 2.00 (1.82–2.20, p\0.001)
Intermediate volume hospitals High-volume hospitals 1.33 (1.22–1.45, p\0.001)
Teaching status Non-teaching status 1.05 (0.96–1.15, p = 0.30)
Rural location Non-rural location 1.16 (0.97–1.38, p = 0.11)
p\0.05 are given in bold.
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123estimate of complication rates using population-based data
onalargegroupofpatientsintheUnitedStatesofallgroups.
The overall 90-day complication rate of 0.68% for mor-
tality, 0.64% for pulmonary embolus, and 1.39% for hip
dislocation was lower than previously reported rates in the
Medicare population of 1.0%, 0.9%, and 3.1%, respectively
[6]. The Swedish Registry reported a similar 90-day mor-
tality rate of 0.76% while the readmission rate was 3.9%
within 30 days [3] (Table 5). The Australian and Finnish
registriesannualreportsdonotdetailcomplicationratesover
periodsshorterthan1-yearsodirectcomparisontoourstudy
is not available [2, 8]. The higher rates of complication in
Medicare analyses may demonstrate the selection bias in the
Medicare population toward older and potentially sicker
patients. Interestingly, our population had a higher wound
infection rate of 0.9% than that previously reported in the
Medicare population of 0.2% [6]. Further research is needed
to elucidate the potential causes for this with respect to
potential differences in the prevalence of diabetes, nosoco-
mial infections, regional variationsin pathogens,orintrinsic
differencesinourCaliforniapopulation.Ourdislocationrate
of 1.39% was similar to previously published data in the
Medicare population for those treated by surgeons who
performedmorethan50THAsperyear,1.5%;however,this
is notably different from the dislocation rate in those treated
bysurgeonswhoperformedﬁveorfewerperyear,whichhas
been reported as 4.2% [6]. Our study demonstrated similar
increasedrisksofdislocationatlower-volumehospitalsafter
adjusting for patient and provider characteristics. These
observationsmaybeusefulfortargetinginterventionswitha
goaltodecrease dislocation andcomplicationratesatlower-
volume centers.
Age, comorbidity, and race/ethnicity had an effect on
the risk of short-term complications similar in magnitude to
that of hospital volume. These ﬁndings are similar to those
reported by Katz et al. who found age, gender, comorbid-
ity, race, and income were associated with a higher risk of
complications in the Medicare population [4]. Conﬁrma-
tion of these observations suggests the need for further
study on the relative importance and underlying causes of
these differences among populations. Future studies of
these predictive factors would beneﬁt from enriched data
sources that include functional outcomes. Identifying these
differing risks may be useful in counseling patients
regarding the risks of surgery. The causes of these differ-
ences between populations warrant additional study to
determine if they should play a role in patient selection or
result in different approaches to perioperative care in
patients at increased risk of complications.
This study reports short-term complication rates fol-
lowing total hip arthroplasty and the role of some patient
and provider factors in predicting the occurrence of com-
plications. The elucidation of these factors is useful in
patient education and discussion of the perioperative risks
of THA in different patient population.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix 1
Inclusion Diagnosis codes – to be ﬂagged
715 degenerative disease
7150 degenerative disease
71500 degenerative disease
71509 degenerative disease
7151 degenerative disease
71510 degenerative disease
71515 degenerative disease
7152 degenerative disease
71520 degenerative disease
71525 degenerative disease
7153 degenerative disease
71530 degenerative disease
71535 degenerative disease
718 degenerative disease
71580 degenerative disease
71585 degenerative disease
71589 degenerative disease
7159 degenerative disease
71590 degenerative disease
71595 degenerative disease
Table 5. Short-term complication rates compared to Swedish Registry and Medicare Database analyses
Complication 90-day
mortality
90-day
dislocation
90-day
thromboembolic
disease
90-day
infection
30-day
readmission
rate
Overall rate of any
complication within
90-days
Katz et al. [4] 1.00% 3.10% 0.90% 0.20% Not reported Not reported
Swedish Registry [3] 0.76% Not reported Not reported Not reported 3.90% Not reported
SooHoo et al. [current study] 0.68% 1.39% 0.64% 0.90% Not reported 3.81%
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123714 rheumatoid arthritis, JRA, and RA with systemic
involvement
7140 rheumatoid arthritis, JRA, and RA with systemic
involvement
7143 rheumatoid arthritis, JRA, and RA with systemic
involvement
71430 rheumatoid arthritis, JRA, and RA with systemic
involvement
71431 rheumatoid arthritis, JRA, and RA with systemic
involvement
71432 rheumatoid arthritis, JRA, and RA with systemic
involvement
71433 rheumatoid arthritis, JRA, and RA with systemic
involvement
7334 AVN
73340 AVN
73342 AVN
7310 Pagets
73300 osteoporosis
73301 osteoporosis
73302 osteoporosis
73303 osteoporosis
73309 osteoporosis
27800 obesity - NOS
27801 obesity - morbid
27802 obesity - overweight
V850 obesity - BMI\19
V851 obesity - BMI 19-24
V8521 obesity - BMI 25-30
V8522 obesity - BMI 25-30
V8523 obesity - BMI 25-30
V8524 obesity - BMI 25-30
V8525 obesity - BMI 25-30
V8530 obesity - BMI 30-40
V8531 obesity - BMI 30-40
V8532 obesity - BMI 30-40
V8533 obesity - BMI 30-40
V8534 obesity - BMI 30-40
V8535 obesity - BMI 30-40
V8536 obesity - BMI 30-40
V8537 obesity - BMI 30-40
V8538 obesity - BMI 30-40
V8539 obesity - BMI 30-40
V854 obesity - BMI[40
Inclusion Procedure codes
8151 total hip replacement
Exclusion Codes –
Procedures
7905 fracture - femur
7915 fracture - femur
7925 fracture - femur
7935 fracture - femur
8153 revision hip replacement
786 removal of implanted device
7860 removal of implanted device
7865 removal of implanted device
800 arthrotomy for removal of prosthesis
8000 arthrotomy for removal of prosthesis
8005 arthrotomy for removal of prosthesis
8153
Diagnosis
820 fracture of neck, shaft, or unspeciﬁed - femur
8200 fracture of neck, shaft, or unspeciﬁed - femur
8200 fracture of neck, shaft, or unspeciﬁed - femur
82001 fracture of neck, shaft, or unspeciﬁed - femur
82001 fracture of neck, shaft, or unspeciﬁed - femur
82003 fracture of neck, shaft, or unspeciﬁed - femur
82009 fracture of neck, shaft, or unspeciﬁed - femur
8201 fracture of neck, shaft, or unspeciﬁed - femur
82010 fracture of neck, shaft, or unspeciﬁed - femur
82011 fracture of neck, shaft, or unspeciﬁed - femur
82012 fracture of neck, shaft, or unspeciﬁed - femur
82013 fracture of neck, shaft, or unspeciﬁed - femur
82019 fracture of neck, shaft, or unspeciﬁed - femur
8202 fracture of neck, shaft, or unspeciﬁed - femur
82020 fracture of neck, shaft, or unspeciﬁed - femur
82021 fracture of neck, shaft, or unspeciﬁed - femur
82022 fracture of neck, shaft, or unspeciﬁed - femur
8203 fracture of neck, shaft, or unspeciﬁed - femur
82030 fracture of neck, shaft, or unspeciﬁed - femur
82031 fracture of neck, shaft, or unspeciﬁed - femur
82032 fracture of neck, shaft, or unspeciﬁed - femur
8208 fracture of neck, shaft, or unspeciﬁed - femur
8209 fracture of neck, shaft, or unspeciﬁed - femur
821 fracture of neck, shaft, or unspeciﬁed - femur
8210 fracture of neck, shaft, or unspeciﬁed - femur
82100 fracture of neck, shaft, or unspeciﬁed - femur
82101 fracture of neck, shaft, or unspeciﬁed - femur
8211 fracture of neck, shaft, or unspeciﬁed - femur
82110 fracture of neck, shaft, or unspeciﬁed - femur
82111 fracture of neck, shaft, or unspeciﬁed - femur
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1238080 acetabulum, closed
8081 acetabulum, open
8082 pubis, closed
8083 pubis, open
80841 ilium, closed
80842 ischium, closed
80843 multiple pelvic, closed
80849 pelvic, other
80851 ilium, open
80852 ischium, open
80853 multiple pelvic, open
80850 other pelvic, open
8088 unspeciﬁed, pelvic, closed
71105 infection - hip
71165 infection - hip
71195 infection - hip
7300 infection - hip
73000 infection - hip
73005 infection - hip
7301 infection - hip
73010 infection - hip
73015 infection - hip
7302 infection - hip
73020 infection - hip
73025 infection - hip
7309 infection - hip
73090 infection - hip
73095 infection - hip
170 malignancy or pathoalogic fracture
1706 malignancy or pathoalogic fracture
1707 malignancy or pathoalogic fracture
1709 malignancy or pathoalogic fracture
1953 malignancy or pathoalogic fracture
1955 malignancy or pathoalogic fracture
198 malignancy or pathoalogic fracture
1985 malignancy or pathoalogic fracture
1990 malignancy or pathoalogic fracture
7331 malignancy or pathoalogic fracture
73314 malignancy or pathoalogic fracture
V540 aftercare for removal of fracture plate
or other ﬁxation device
9964 complications of implant
9966 complications of implant
99660 complications of implant
99666 complications of implant
99667 complications of implant
9967 complications of implant
99670 complications of implant
99677 complications of implant
99678 complications of implant
Outcome diagnosis of Interest
* Code descriptions ending in an * also require a V-code
(to specify the joint)
41511 DVT/PE - iatrogenic pulmonary embolism and
infarction
41519 DVT/PE - pulmonary embolism and infarction,
other
45340 DVT/PE - deep venous thrombosis of lower
extremity
45341 DVT/PE - DVT of proximal lower extremity
45342 DVT/PE - DVT of distal lower extremity
711 infection - arthropathy associated with
infections
7110 infection - pyogenic arthritis
71100 infection - pyogenic arthritis, site unspeciﬁed
71105 infection - pyogenic arthritis, pelvic region and
thigh
7116 infection - mycotic arthropathy
71160 infection - mycotic arthropathy, site unspeciﬁed
71165 infection - mycotic arthropathy, pelvic region and
thigh
7119 infection - unspeciﬁed infective arthritis
71190 infection - unspeciﬁed infective arthritis, site
unspeciﬁed
71195 infection - unspeciﬁed infective arthritis, pelvic
region and thigh
7300 infection - acute osteomyelitis
73000 infection - acute osteomyelitis, site unspeciﬁed
73005 infection - acute osteomyelitis, pelvic region and
thigh
7301 infection - chronic osteomyelitis
73010 infection - chronic osteomyelitis, site unspeciﬁed
73015 infection - chronic osteomyelitis, pelvic region
and thigh
7302 infection - unspeciﬁed osteomyelitis
73020 infection - unspeciﬁed osteomyelitis, site
unspeciﬁed
73025 infection - unspeciﬁed osteomyelitis, pelvic
region and thigh
7309 infection - unspeciﬁed
73090 infection - unspeciﬁed unspeciﬁed site
73095 infection - unspeciﬁed infection of bone, pelvic
region and thigh
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12399640 mechanical complication - unspeciﬁed
mechanical complication of internal orthopedic
device, implant, graft *
99641 mechanical complication - mechanical loosening
of prosthetic joint *
99642 mechanical complication - dislocation of
prosthetic joint *
99643 mechanical complication - prosthetic implant joint
failure *
99644 mechanical complication - peri prosthetic fracture
around prosthetic joint*
99645 mechanical complication - peri-prosthetic
osteolysis *
99646 mechanical complication - articular bearing
surface wear of prosthetic joint *
99647 mechanical complication - other mechanical
complication of prosthetic joint implant *
99649 mechanical complication - other mechanical
complication of other internal orthopedic device,
implant, and graft *
99811 hemorrahge, hematoma, or seroma complicating a
procedure
99812 hemorrahge, hematoma, or seroma complicating a
procedure
99813 hemorrahge, hematoma, or seroma complicating a
procedure
9982 neurovascular - accidental puncture or laceration
during procedure on vessel, nerve, organ
9966 infection and inﬂammatory reaction due to joint
prosthesis *
786 removal of implanted device from bone
7860 removal of implanted device from bone, site
unspeciﬁed
7865 removal of implant device from bone, femur
800 arthrotomy for removal of prosthesis
8000 arthrotomy for removal of prosthesis, site
unspeciﬁed
8005 arthrotomy for removal of prosthesis, hip
801 arthrotomy, other
8010 arthrotomy, other, site unspeciﬁed
8015 arthrotomy, other, hip
7975 closed reduction, hip
7985 open reduction, hip
8153 revision arthroplasty - Revision of hip replacement
8622 I and D - excisional debridement of wound,
infection, burn
8628 I and D - nonexcisional debridement of wound,
infection, burn
7765 I and D - local excision of lesion or tissue of bone,
femur
Valid V codes – only used for outcomes with a *
V4364 v - hip
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